A

27201 publications

1. Anti-Microbial Resistance in Global Perspective
2. Anti-Money Laundering
3. Anti-Money Laundering in a Nutshell
4. Anti-Money Laundering, Counter Financing Terrorism and Cybersecurity in the Banking Industry
5. Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
6. Anti-Oppressive Social Work Theory and Practice
7. Anti-Parliamentary Communism
8. Anti-Poverty Psychology
9. Anti-Press Violence in Subnational Undemocratic Regimes
10. Anti-Proverbs in Five Languages
11. Anti-Racist Movements in the EU
12. Anti-Racist Social Work
13. Anti-Semitism and British Gothic Literature
14. Anti-Semitism and Psychiatry
15. Anti-Semitism in Contemporary Malaysia
16. Anti-Social Behaviour Orders
17. Anti-Sozial-Front
18. Anti-Spam Measures
19. Anti-Submarine Warfare and Superpower Strategic Stability
20. Anti-Suit Injunctions in FRAND-Streitigkeiten
21. Anti-Viral Metabolites from Medicinal Plants
22. Anti-Viral Metabolites from Medicinal Plants
23. Anti-Vivisection and the Profession of Medicine in Britain
24. Anti-War Activism
25. Anti-War Theatre After Brecht
26. Anti-Zionism and Antisemitism in the Contemporary World
27. Anti-asiatischer Rassismus und gender
28. Anti-corruption Education and Peacebuilding
29. Anti-diabetes and Anti-obesity Medicinal Plants and Phytochemicals
30. Anti-fragile ICT Systems
31. Anti-inflammatory Nutraceuticals and Chronic Diseases
32. Anti-militarism
33. Anti-money Laundering Law: Socio-legal Perspectives on the Effectiveness of German Practices
34. Anti-personnel Landmine Detection for Humanitarian Demining
35. Anti-reflection and Light Trapping in c-Si Solar Cells
36. Anti-social Behaviour in Britain
37. Antiaesthetics
38. Antiandrogens in Prostate Cancer
39. Antianginal Drugs
40. Antiangiogenic Agents in Cancer Therapy
41. Antiangiogenic Agents in Cancer Therapy
42. Antiarrhythmic Drugs
43. Antiarrhythmic Drugs
44. Antiarrhythmic Drugs
45. Antiautoritäre Erziehung in der Kinderladenbewegung
46. Antibacterial Chemotherapeutic Agents
47. Antibacterial Drug Discovery to Combat MDR
48. Antibacterial Drugs Today
49. Antibacterial Peptide Protocols
50. Antibacterial Surfaces
51. Antibacterial Therapy: Achievements, Problems and Future Perspectives
52. Antibacterials
53. Antibacterials
54. Antibakterielle Therapie
55. Antibiofilm Agents
56. Antibiofilm Strategies
57. Antibiosis and Host Immunity
58. Antibiotic Associated Diarrhoea and Colitis
59. Antibiotic Discovery and Development
60. Antibiotic Pharmacodynamics
61. Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill
62. Antibiotic Policies
63. Antibiotic Policies
64. Antibiotic Policies: Fighting Resistance
65. Antibiotic Resistance
66. Antibiotic Resistance Protocols
67. Antibiotic Resistance Protocols
68. Antibiotic Resistance Protocols
69. Antibiotic Resistance in the Environment
70. Antibiotic Resistant Bacteria: A Challenge to Modern Medicine
71. Antibiotic Resistence
72. Antibiotic Stewardship im Krankenhaus
73. Antibiotic Stewardship in Arztpraxis und Ambulanz
74. Antibiotic and Antifungal Therapies in Dermatology
75. Antibiotica en infecties
76. Antibiotics
77. Antibiotics
78. Antibiotics
79. Antibiotics
80. Antibiotics
81. Antibiotics
82. Antibiotics
83. Antibiotics
84. Antibiotics and Antibiotics Resistance Genes in Soils
85. Antibiotics and Antimicrobial Resistance Genes
86. Antibiotics and Chemotherapy
87. Antibiotics as Anti-Inflammatory and Immunomodulatory Agents
88. Antibiotics in Obstetrics and Gynecology
89. Antibiotics in the Tropics
90. Antibiotika am Krankenbett
91. Antibiotika am Krankenbett
92. Antibiotika am Krankenbett
93. Antibiotika am Krankenbett
94. Antibiotika am Krankenbett
95. Antibiotika am Krankenbett
96. Antibiotika am Krankenbett
97. Antibiotika am Krankenbett
98. Antibiotika am Krankenbett
99. Antibiotika am Krankenbett
100. Antibiotika am Krankenbett
101. Antibiotika am Krankenbett
102. Antibiotika am Krankenbett
103. Antibiotika am Krankenbett
104. Antibiotika am Krankenbett 2019 - 2020
105. Antibiotika bei Infektionen mit multiresistenten Erregern
106. Antibiotika bei Infektionen mit multiresistenten Erregern
107. Antibiotika in der Praxis 2019 - 2020
108. Antibiotika in der Praxis mit Hygieneratschlägen
109. Antibiotika in der Praxis mit Hygieneratschlägen
110. Antibiotika in der Praxis mit Hygieneratschlägen
111. Antibiotika in der Praxis mit Hygieneratschlägen
112. Antibiotika in der Praxis mit Hygieneratschlägen
113. Antibiotika in der Praxis mit Hygieneratschlägen
114. Antibiotika in der Praxis mit Hygieneratschlägen
115. Antibiotika in der Praxis mit Hygieneratschlägen
116. Antibiotikatherapie im Kindesalter
117. Antiblack Racism and the AIDS Epidemic
118. Antibodies
119. Antibodies
120. Antibodies
121. Antibodies
122. Antibodies for Treating Cancer
123. Antibodies in Cytokines
124. Antibody Arrays
125. Antibody Engineering
126. Antibody Engineering
127. Antibody Engineering
128. Antibody Engineering
129. Antibody Engineering
130. Antibody Engineering
131. Antibody Engineering Protocols
132. Antibody Expression and Production
133. Antibody Glycosylation
134. Antibody Methods and Protocols
135. Antibody Phage Display
136. Antibody Phage Display
137. Antibody Therapy
138. Antibody Usage in the Lab
139. Antibody-Drug Conjugates
140. Antibody-Drug Conjugates
141. Antibody-Drug Conjugates
142. Antibody-Drug Conjugates and Cellular Metabolic Dynamics
143. Antibody-Drug Conjugates and Immunotoxins
144. Anticancer Drug Development Guide
145. Anticancer Drug Development Guide
146. Anticancer Drug Discovery and Development: Natural Products and New Molecular Models
147. Anticancer Drug Resistance
148. Anticancer Genes
149. Anticancer Plants: Clinical Trials and Nanotechnology
150. Anticancer Plants: Mechanisms and Molecular Interactions
151. Anticancer Plants: Natural Products and Biotechnological Implements
152. Anticancer plants: Properties and Application
153. Anticarbohydrate Antibodies
154. Anticarcinogenesis and Radiation Protection
155. Anticarcinogenesis and Radiation Protection 2
156. Anticipated and Abnormal Plant Transients in Light Water Reactors
157. Anticipated and Deferred Corporate Income Tax in Companies’ Financial Statements
158. Anticipating Future Innovation Pathways Through Large Data Analysis
159. Anticipating and Assessing Health Care Technology
160. Anticipating and Assessing Health Care Technology
161. Anticipating and Assessing Health Care Technology
162. Anticipating and Assessing Health Care Technology
163. Anticipating and Assessing Health Care Technology
164. Anticipating and Preparing for Emerging Skills and Jobs
165. Anticipation Across Disciplines
166. Anticipation and Medicine
167. Anticipation, Agency and Complexity
168. Anticipation: Learning from the Past
169. Anticipative Criminal Investigation
170. Anticipatory Action in Self-Defence
171. Anticipatory Behavior in Adaptive Learning Systems
172. Anticipatory Behavior in Adaptive Learning Systems
173. Anticipatory Behavior in Adaptive Learning Systems
174. Anticipatory Ethics and The Use of CRISPR in Humans
175. Anticipatory Learning Classifier Systems
176. Anticipatory Materialisms in Literature and Philosophy, 1790–1930
177. Anticipatory Optimization for Dynamic Decision Making
178. Anticipatory Systems
179. Anticlastogens in Mammalian and Human Cells
180. Anticoagulant Rodenticides and Wildlife
181. Anticoagulants, Antiplatelets, and Thrombolytics
182. Anticoagulants, Antiplatelets, and Thrombolytics
183. Anticoagulation
184. Anticoagulation Management
185. Anticoagulation Therapy
186. Anticoagulation and Hemostasis in Neurosurgery
187. Anticommunism and the African American Freedom Movement
188. Anticonceptie
189. Antidepressants
190. Antidepressants
191. Antidepressants
192. Antidepressants for Elderly People
193. Antidepressants: Past, Present and Future
194. Antidepressiva und Depressionsbehandlung in der ärztlichen Praxis
195. Antidiskriminierungspädagogik
196. Antiemetics in the Supportive Care of Cancer Patients
197. Antiepileptic Drug Discovery
198. Antiepileptic Drug Interactions
199. Antiepileptic Drug Interactions
200. Antiepileptic Drugs